CT scans predict chemo penetration and effectiveness in new study; Oramed wins oral diabetes treatment patent in Australia;

> In a new study from the University of Texas, CT scans have shown to be effective at reflecting how well chemotherapy will penetrate a pancreatic tumor and predicting how well a treatment would work. More

> Oramed won its third patent in Australia for the oral administration of exenatide, a diabetes treatment. Release

> Orexo teamed up with UnitedHealth Group and OptumRx for coverage and reimbursement of its sublingual opioid dependence treatment, Zubzolv. Release

Suggested Articles

Zosano will need to run additional studies and await an FDA inspection to address the agency's complete response letter on its migraine patch Qtrypta.

Nanoform Finland tapped Quotient Sciences to help run the first in-human trial of a drug developed using its 'nanoforming' technology later this year.

Swiss scientists are using ultrasound to trap and deliver drugs in the brain, a non-invasive delivery method that could help target tumors, too.